Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 5;13(1):8847.
doi: 10.4081/hr.2021.8847.

Long-term and quality of survival in patients treated for acute lymphoblastic leukemia during the pediatric age

Lara Devilli  1 , Chiara Garonzi  1 , Rita Balter  1 , Elisa Bonetti  1 , Matteo Chinello  1 , Ada Zaccaron  1 , Virginia Vitale  1 , Massimilano De Bortoli  1 , Giulia Caddeo  1 , Valentina Baretta  1 , Gloria Tridello  1 , Simone Cesaro  1
Affiliations

Long-term and quality of survival in patients treated for acute lymphoblastic leukemia during the pediatric age

Lara Devilli et al. Hematol Rep. .

Abstract

Long-term survival for acute lymphoblastic leukemia (ALL) in children improved over the last three decades up to 80-90% of affected patients. Consequently, the quality of life of survivors has become increasingly important. This study analyses the clinical features and outcome of 119 children with ALL, focusing on the quality of long-term survival in a subset of 22 patients over 18 years of age. Among this group, the 10-year event-free survival and overall survival were 83.1% (C.I. 74.0-89.2) and 88.4% (C.I. 80.9-93.1), respectively. Treatment related long-term medical complications were reported only in 2 patients (9.1%). Secondary school was completed successfully in 20 of 22 patients (89.9%). The remaining 2 patients were still attending at the time of the analysis. In conclusion, current treatment for ALL is well tolerated and does not compromise significantly the quality of life of survivors.

Keywords: acute lymphoblastic leukemia; pediatric leukemia; survival.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: the authors declare no conflict of interests.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Hunger SP, Lu X, Devidas M, et al. . Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children’s oncology group. J Clin Oncol 2012;30:1663-9. - PMC - PubMed
    1. Silverman LB, Stevenson KE, Brien JEO, et al. . Long-term results of danafarber cancer institute all consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985–2000). Leukemia 2010;24:320-34. - PMC - PubMed
    1. Rizzari C, Lanvers-kaminsky C, Valsecchi MG, et al. . Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the in the induction phase of the AIEOP-BFM ALL 2009 study. Haematologica 2019;104:1812-21. - PMC - PubMed
    1. Conter V, Bartram CR, Valsecchi MG, et al. . Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOPBFM ALL 2000 study. Blood 2010;115:3206-14. - PubMed
    1. Conter V, Aricò M, Basso G, et al. . Longterm results of the Italian association of pediatric hematology and oncology (AIEOP) studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia. Leukemia 2010;24:255–64. - PubMed

LinkOut - more resources